Progressive arterial occlusive disease (PAOD) and pulmonary arterial hypertension (PAH) as new adverse events of second generation TKIs in CML treatment: who's afraid of the big bad wolf?
作者信息
Breccia Massimo, Efficace Fabio, Alimena Giuliana
机构信息
Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
出版信息
Leuk Res. 2012 Jul;36(7):813-4. doi: 10.1016/j.leukres.2012.03.010. Epub 2012 Apr 5.
Abstract
摘要
Zotero 插件